Reimbursed Care Access in Cuba

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. #

There is no public evidence of a Cuban national marketing authorisation, national reimbursement listing, or REMS‑style program for esketamine (Spravato). Spravato (esketamine) is approved and distributed under restricted programs in jurisdictions such as the United States, where it is subject to a REMS and pharmacy/clinic controls # and has been commercially promoted by its manufacturer in approved markets #. However, I find no official Cuban Ministry of Public Health (MINSAP) listing or government press indicating national approval or public reimbursement of esketamine; therefore esketamine is not considered an available, covered treatment in Cuba (access would require an explicit national approval or sanctioned import pathway, neither of which is publicly documented).

Ketamine is an established anaesthetic and analgesic agent listed on the WHO Model List of Essential Medicines for use as an injectable anaesthetic, and it is widely used in medical systems globally for surgical and emergency care. #.

In Cuba specifically, ketamine appears on national control/resolution lists for psychopharmaceuticals — reflecting both its legitimate medical/anaesthetic role and tight regulatory control due to potential diversion and misuse. A published summary of Cuban regulatory measures and reporting on a national resolution includes ketamine among medicines placed under special national control and subject to import/export/possession restrictions when not authorised for official medical use. This indicates ketamine is used in Cuban clinical settings (e.g., anaesthesia in hospitals) under state health system supply chains but is tightly monitored by MINSAP and criminal justice bodies for diversion. #; further reporting notes ketamine on lists that restrict entry/exit of certain controlled medicines and require prior authorisation when part of official medical kits. #.

Practical implications: (1) Ketamine is available within Cuban hospitals for approved anaesthetic and analgesic indications and is controlled centrally by the state health system; (2) There is no publicly available evidence of a government‑funded, reimbursed program in Cuba for ketamine in psychiatric indications (e.g., treatment‑resistant depression), and off‑label psychiatric use would be subject to institutional policy and local regulatory approval; (3) diversion, non‑medical possession, or unauthorised distribution can lead to criminal prosecution under Cuban drug control and judicial rulings that have recently reinforced penalties for synthetic/controlled substances. #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Note that at international level DMT is controlled (UN schedules), and most national systems, including Cuba’s, treat DMT as a prohibited Schedule I‑type compound. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. (No evidence of licensed ibogaine clinics or national treatment guidance in Cuba.) #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Although ayahuasca is a plant brew, its primary psychoactive constituent (DMT) is controlled and Cuba enforces restrictions on DMT‑containing substances. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. (Mescaline is internationally controlled and Cuba’s drug policy and penal code treat classical hallucinogens as illicit outside authorised research.) #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Cuban authorities have also been active in criminal enforcement and tightened penalties for synthetic/new psychoactive substances in recent judicial guidance. #